Status:
UNKNOWN
Metabolomics in Small Intestinal Bacterial Overgrowth
Lead Sponsor:
United Lincolnshire Hospitals NHS Trust
Conditions:
Small Intestine Problem
Eligibility:
All Genders
18-50 years
Brief Summary
Small intestinal bacterial overgrowth (SIBO) is a condition where a person's own good and useful germs, live in parts of the bowel where there should not be any germs. It may cause difficult tummy and...
Eligibility Criteria
Inclusion
- Adults aged ≥ 18 and ≤ 50
- Absence of red flag symptoms i.e. unexplained weight loss, a palpable mass, unexplained iron deficiency anaemia or rectal bleeding
- GI symptoms which are due to possible SIBO
- Capacity to give informed consent
Exclusion
- Presence of red flag symptoms (specified above in inclusion criteria)
- Previous GI surgery including cholecystectomy (except appendicectomy, inguinal/femoral hernia repair or Caesarean sections)
- Past history of inflammatory bowel disease, coeliac disease or pancreatic disease
- Past history of cancer (except basal cell carcinoma)
- Female patients who are pregnant
- Inability to adequately understand verbal or written information
- Inability or unwillingness to give informed consent
- Unwilling to consider taking antibiotics to treat SIBO
- Incapacity to comply with the demands of the study
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04057560
Start Date
November 1 2019
End Date
September 1 2020
Last Update
October 29 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.